Diet-related diseases are the leading cause of death in the United States. Glickman previously wrote in the New York Times, publicly calling on the National Institutes of Health to establish a new body specializing in nutrition research:
We study major diseases such as heart disease, cancer, arthritis and Alzheimer's disease, but we haven't done enough to prevent them, and food is a big part of them.
I certainly support plant-based meat, but I don't think anyone should see it as Nirvana or the only way to solve problems.
This year, Beyond Meat, a man-made meat concept stock, has been popular in the market. Since its May 2 listing, its share price has risen by more than 200% over its $25 IPO price.
Barclays analysts had predicted that "artificial meat" would become an industry worth $140 billion over the next 10 years.
Alexia Howard, an analyst at Bernstein, points out that the U.S. market for artificial meat alone is expected to reach $40.5 billion over the next decade.
It points out that although Beyond Meat is under pressure from strong competitors such as Impossible Foods in the industry, the growing demand for artificial meat will enable the industry to accommodate more brands. On the other hand, the rising pork prices caused by African swine fever in China will also be a good factor for artificial meat products.
Earlier, Impossible Foods, another "artificial meat" company, received a new round of $300 million in financing led by Temasek and Horizons Ventures, bringing its valuation to $2 billion.
The company has just announced a partnership with Burger King, a famous fast food chain in the United States. Burger King announced that it would use the company's artificial meat to launch Impossible Whopper in more than 7,000 stores. Burger King intends to bring the new product to the international market by the end of this year.